Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Miyajima, Yusuke
55  Ergebnisse:
OpenAccess-Volltexte X
Personensuche X
?
1

Helicobacter fennelliae Localization to Diffuse Areas of Hu..:

Sakoh, Takashi ; Miyajima, Emiko ; Endo, Yusuke...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10756365/.  , 2024
Link: http://www.ncbi.nlm.nih...
 
?
2

Analysis of distribution, collection, and confirmation of c..:

Takeda, Nobutaka ; Tsuchiya, Atsunori ; Mito, Masaki...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10561446/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
3

Analysis of distribution, collection, and confirmation of c..:

Nobutaka Takeda ; Atsunori Tsuchiya ; Masaki Mito...
https://doi.org/10.1186/s41232-023-00299-x.  , 2023
Link: https://doi.org/10.1186/..
 
?
4

Neutralizing Antibody Response of the Wild-Type/Omicron BA...:

Kawasuji, Hitoshi ; Morinaga, Yoshitomo ; Tani, Hideki...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10101054/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
5

Machine-learning detection of the Berezinskii-Kosterlitz-Th..:

Miyajima, Yusuke ; Mochizuki, Masahito
http://arxiv.org/abs/2304.08871.  , 2023
Link: http://arxiv.org/abs/230..
 
?
6

Cumulative risk of developing a new symptom in patients wit..:

Naruhiro Kimura ; Toru Setsu ; Yoshihisa Arao...
https://doi.org/10.1002/jgh3.12789.  , 2022
Link: https://doi.org/10.1002/..
 
?
7

Effect of Casirivimab/Imdevimab Treatment on Serum Type I I..:

Kentaro Nagaoka ; Hitoshi Kawasuji ; Yusuke Takegoshi...
https://www.mdpi.com/1999-4915/14/7/1399.  , 2022
Link: https://doi.org/10.3390/..
 
?
8

Effect of Casirivimab/Imdevimab Treatment on Serum Type I I..:

Kentaro Nagaoka ; Hitoshi Kawasuji ; Yusuke Takegoshi...
SARS-CoV-2 and COVID-19.  , 2022
Link: https://doi.org/10.3390/..
 
?
9

Effect of Casirivimab/Imdevimab Treatment on Serum Type I I..:

Nagaoka, Kentaro ; Kawasuji, Hitoshi ; Takegoshi, Yusuke...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9318908/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
10

Cumulative risk of developing a new symptom in patients wit..:

Kimura, Naruhiro ; Setsu, Toru ; Arao, Yoshihisa...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9344586/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
11

Small extracellular vesicles derived from interferon-γ pre-..:

Suguru Takeuchi ; Atsunori Tsuchiya ; Takahiro Iwasawa...
https://doi.org/10.1038/s41536-021-00132-4.  , 2021
Link: https://doi.org/10.1038/..
 
?
12

Early prediction of COVID‐19 severity using extracellular v..:

Yu Fujita ; Tokio Hoshina ; Juntaro Matsuzaki...
https://doi.org/10.1002/jev2.12092.  , 2021
Link: https://doi.org/10.1002/..
 
?
13

Development of human iPSC-derived quiescent hepatic stellat..:

Koui, Yuta ; Himeno, Misao ; Mori, Yusuke...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8693663/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
14

A case of COVID-19 diagnosed with favipiravir-induced drug ..:

Yushi Murai ; Hitoshi Kawasuji ; Yusuke Takegoshi...
http://www.sciencedirect.com/science/article/pii/S1201971221002666.  , 2021
Link: https://doi.org/10.1016/..
 
?
15

Delayed neutralizing antibody response in the acute phase c..:

Hitoshi Kawasuji ; Yoshitomo Morinaga ; Hideki Tani...
https://doi.org/10.1038/s41598-021-96143-8.  , 2021
Link: https://doi.org/10.1038/..
 
1-15